Dexcom Inc. Stock
Price
Target price
€109.48
€109.48
-1.720%
-1.88
-1.720%
€136.80
31.05.24 / Tradegate
WKN: A0D9T1 / Symbol: DXCM / Name: DexCom / Stock / Healthcare Equipment & Supplies / Large Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Dexcom Inc. Stock
A loss of -1.720% shows a downward development for Dexcom Inc..
Dexcom Inc. is currently one of the favorites of our community with 18 Buy predictions and no Sell predictions.
With a target price of 136 € there is a positive potential of 24.22% for Dexcom Inc. compared to the current price of 109.48 €.
Our community identified positive and negative aspects for Dexcom Inc. stock for the coming years. 3 users see the criterium "Worthwhile Investment for the next years" as a plus for the Dexcom Inc. stock. On the other hand our users think that "General Risks" could be a problem in the future.
Pros and Cons of Dexcom Inc. in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
S********** s********
?
C******** o* t** e**********
Cons
?
B****
?
M***** P*******
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Dexcom Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Dexcom Inc. | -1.720% | -6.730% | -8.293% | -0.273% | -2.215% | 44.100% | 305.481% |
| Dentsply Sirona Inc. | 0.390% | 1.935% | -8.215% | -23.639% | -19.795% | -52.850% | -46.463% |
| Zimmer Holdings | -0.330% | -1.164% | -6.561% | -10.990% | -3.545% | -21.232% | 3.290% |
| Teleflex Inc. | 1.050% | 1.579% | -1.026% | -11.468% | -14.602% | -41.515% | - |
Comments
DexCom, Inc. (NASDAQ: DXCM) had its price target raised by analysts at Raymond James from $151.00 to $160.00. They now have a "strong-buy" rating on the stock.
Show more
Ratings data for DXCM provided by MarketBeat
DexCom, Inc. (NASDAQ: DXCM) had its price target raised by analysts at UBS Group AG from $153.00 to $163.00. They now have a "buy" rating on the stock.
Show more
Ratings data for DXCM provided by MarketBeat
DexCom, Inc. (NASDAQ: DXCM) had its price target raised by analysts at Citigroup Inc. from $148.00 to $161.00. They now have a "buy" rating on the stock.
Show more
Ratings data for DXCM provided by MarketBeat
News
Should Abbott and DexCom Investors Be Worried About Vertex Pharmaceuticals?
Successful investors think about the future by focusing on what the new opportunities might be. They also pay attention to threats that could emerge that might impact the stocks they own. Sometimes
Dexcom Announces Upcoming Conference Presentation
DexCom, Inc. (NASDAQ:DXCM) today announced that Jereme Sylvain, Executive Vice President and Chief Financial Officer, will present an update on the company at the William Blair 44th Annual Growth
Dexcom Launches Innovative New Sensor as Groundbreaking Report Reveals Alarming Rates of Anxiety and Depression in Those With Type 2 Diabetes
DexCom, Inc. (Nasdaq: DXCM), a global leader in real-time continuous glucose monitoring (CGM) for people with diabetes, today announced both the launch of Dexcom ONE+, a CGM device that easily